MR编号 | AT/H/1374/002 |
---|
药品名称 | Beclometasone formoterol Genetic 200/6 micrograms per actuation |
---|
活性成分 | - Beclometasone dipropionate 200.0 µg
- Formoterolfumarat dihydrate 6.0 µg
|
---|
剂型 | Pressurised inhalation, solution |
---|
上市许可持有人 | Genetic S.p.A.
Via G. Della Monica 26
84083 Salerno
Italy |
---|
参考成员国 - 产品名称 | Austria (AT) |
---|
互认成员国 - 产品名称 | - Portugal (PT)
- Romania (RO)
- Spain (ES)
- Czechia (CZ)
beclometasoni formoteroli Genetic 200 mikrogramů/6 mikrogramů/dávka roztok k inhalaci v tlakovém obalu - France (FR)
- Cyprus (CY)
Beclometasone formoterol Genetic 200 microgram/6 microgram per actuation pressurized inhalation solution - Ireland (IE)
- Bulgaria (BG)
Beclomethasone formoterol Generic - Luxembourg (LU)
- Hungary (HU)
- Netherlands (NL)
- Estonia (EE)
- Belgium (BE)
- Lithuania (LT)
- - Germany (DE)
Beclometason/Formoterol Genetic 200 Mikrogramm/6 Mikrogramm pro Inhalation Druckgasinhalation, Lösung - Latvia (LV)
- Croatia (HR)
- Poland (PL)
- Malta (MT)
Beclometasone formoterol Genetic 200 microgram/6 microgram per actuation pressurized inhalation solution - Greece (GR)
- Italy (IT)
- Slovakia (SK)
- Slovenia (SI)
|
---|
许可日期 | 2024/10/23 |
---|
最近更新日期 | 2024/10/23 |
---|
药物ATC编码 | - R03AK08 formoterol and beclometasone
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|